Background Current guidelines recommend using aspirin, clopidogrel, beta-blockers,
statins, and angiotensin converting enzyme (ACE) inhibitors after acute myocardial infarction …

Objectives: We sought to assess the relationship between increasing use of cardiovascular
medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly …

The objective of this study was to determine the management and outcome of fewer selected
patients with an acute coronary syndrome during hospitalization and up to 1 year after …

Background: In an accompanying article, we report moderate between-hospital variation in
the postdischarge use of β-blockers, angiotensin-modifying drugs and statins by elderly …

Aims To study initiation, dosages, and compliance with beta-blockers, angiotensin-
converting enzyme (ACE)-inhibitors, and statins in patients after acute myocardial infarction …

OBJECTIVE: There is a limited amount of literature examining the burden and cost of illness
of acute coronary syndrome (ACS) in the managed care population. The goal of this study …

Aim: To review and document the current utilization of pharmacotherapy for the secondary
prevention of acute coronary syndromes (ACS) in patients discharged from an Australian …

Background Persistent use of secondary prevention therapies after acute myocardial
infarction (MI) is critical to optimizing long-term outcomes. Methods Medication persistence …

OBJECTIVES: To describe the persistent use of evidence‐based cardiovascular
medications (EBCMs) 3 months after discharge from an acute coronary syndrome (ACS) …

Background Secondary prevention pharmacotherapy improves outcomes after acute
coronary syndrome (ACS). However, poor medication adherence is common, and various …